peptide,lca,superkingdom,kingdom,subkingdom,superphylum,phylum,subphylum,superclass,class,subclass,infraclass,superorder,order,suborder,infraorder,parvorder,superfamily,family,subfamily,tribe,subtribe,genus,subgenus,species group,species subgroup,species,subspecies,varietas,forma,EC,EC - names,GO (cellular component),GO (molecular function),GO (biological process),GO (cellular component) - names,GO (molecular function) - names,GO (biological process) - names,InterPro,InterPro - names
LSSPATLNSR,Mammalia,Eukaryota,Metazoa,,,Chordata,Craniata,Sarcopterygii,Mammalia,,,,,,,,,,,,,,,,,,,,,3.4.21.4 (100%),Trypsin (100%),GO:0005615 (11%);GO:0016021 (2%),extracellular space (11%);integral component of membrane (2%),GO:0004252 (100%);GO:0046872 (4%),serine-type endopeptidase activity (100%);metal ion binding (4%),GO:0006508 (11%);GO:0007586 (4%),proteolysis (11%);digestion (4%),IPR001254 (100%);IPR009003 (100%);IPR043504 (100%),Serine proteases, trypsin domain (100%);Peptidase S1, PA clan (100%);Peptidase S1, PA clan, chymotrypsin-like fold (100%)
LATVLSPR,Gammaproteobacteria,Bacteria,,,,Proteobacteria,,,Gammaproteobacteria,,,,,,,,,,,,,,,,,,,,,,,,,,,,,IPR002634 (100%);IPR036065 (100%),BolA protein (100%);BolA-like superfamily (100%)
VATVSPLR,Solirubrobacteraceae,Bacteria,,,,Actinobacteria,,,Thermoleophilia,,,Solirubrobacterales,,,,Solirubrobacteraceae,,,,,,,,,,,,,,,,GO:0005886 (100%);GO:0016021 (100%),plasma membrane (100%);integral component of membrane (100%),,,,,IPR003838 (100%);IPR025857 (100%),ABC3 transporter permease protein domain (100%);MacB-like periplasmic core domain (100%)
VVTVSLPR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0005524 (100%);GO:0008134 (100%);GO:0043565 (100%),ATP binding (100%);transcription factor binding (100%);sequence-specific DNA binding (100%),GO:0000160 (100%);GO:0006355 (100%),phosphorelay signal transduction system (100%);regulation of transcription, DNA-templated (100%),IPR001789 (100%);IPR002078 (100%);IPR002197 (100%),Signal transduction response regulator, receiver domain (100%);RNA polymerase sigma factor 54 interaction domain (100%);DNA binding HTH domain,  Fis-type (100%)
VVTVLSPR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0007165 (100%),signal transduction (100%),IPR000157 (100%);IPR035897 (100%),Toll/interleukin-1 receptor homology (TIR) domain (100%);Toll/interleukin-1 receptor homology (TIR) domain superfamily (100%)
MVLDAWFK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
NQYLSWVVEVK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
ELYLSWVVEAR,Sarcopterygii,Eukaryota,Metazoa,,,Chordata,Craniata,Sarcopterygii,,,,,,,,,,,,,,,,,,,,,,1.6.2.4 (100%),NADPH--hemoprotein reductase (100%),GO:0016021 (90%);GO:0005789 (76%);GO:0005783 (8%),integral component of membrane (90%);endoplasmic reticulum membrane (76%);endoplasmic reticulum (8%),GO:0010181 (95%);GO:0003958 (88%);GO:0050660 (76%),FMN binding (95%);NADPH-hemoprotein reductase activity (88%);flavin adenine dinucleotide binding (76%),GO:0009725 (5%);GO:0003420 (2%);GO:0007584 (2%),response to hormone (5%);regulation of growth plate cartilage chondrocyte proliferation (2%);response to nutrient (2%),IPR003097 (100%);IPR017938 (100%);IPR023173 (100%),Sulfite reductase [NADPH] flavoprotein alpha-component-like, FAD-binding (100%);Riboflavin synthase-like beta-barrel (100%);NADPH-cytochrome p450 reductase, FAD-binding, alpha-helical domain superfamily (100%)
LSSPATLSNR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MVDLAWFK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MVDLAAVYK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
DMLQYK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.4.11.4 (57%);2.1.1.72 (14%);2.7.10.2 (14%),Tripeptide aminopeptidase (57%);Site-specific DNA-methyltransferase (adenine-specific) (14%);Non-specific protein-tyrosine kinase (14%),GO:0016021 (16%);GO:0005737 (13%);GO:0005886 (6%),integral component of membrane (16%);cytoplasm (13%);plasma membrane (6%),GO:0008168 (35%);GO:0008237 (13%);GO:0008270 (13%),methyltransferase activity (35%);metallopeptidase activity (13%);zinc ion binding (13%),GO:0032259 (35%);GO:0043171 (13%);GO:0006310 (6%),methylation (35%);peptide catabolic process (13%);DNA recombination (6%),IPR001261 (18%);IPR002933 (18%);IPR010161 (18%),ArgE/DapE/ACY1/CPG2/YscS, conserved site (18%);Peptidase M20 (18%);Peptidase M20B, tripeptide aminopeptidase (18%)
HMFPHLYVPR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VGPVSLPR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0016021 (100%),integral component of membrane (100%),,,GO:0051301 (80%),cell division (80%),IPR001182 (100%),Probable peptidoglycan glycosyltransferase FtsW/RodA (100%)
VPGVSLPR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VVSLLSPR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,5.1.1.3 (100%),Glutamate racemase (100%),GO:0005886 (20%);GO:0016021 (20%),plasma membrane (20%);integral component of membrane (20%),GO:0016832 (40%);GO:0008881 (20%);GO:0016810 (20%),aldehyde-lyase activity (40%);glutamate racemase activity (20%);hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds (20%),GO:0005975 (40%);GO:0008360 (20%);GO:0009252 (20%),carbohydrate metabolic process (40%);regulation of cell shape (20%);peptidoglycan biosynthetic process (20%),IPR005475 (33%);IPR005593 (33%);IPR009014 (33%),Transketolase-like, pyrimidine-binding domain (33%);Xylulose 5-phosphate/Fructose 6-phosphate phosphoketolase (33%);Transketolase C-terminal/Pyruvate-ferredoxin oxidoreductase domain II (33%)
HMLMHLYVPR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MHFPHLYVPR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SPCHR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.1.4.- (44%);2.7.7.7 (19%);5.2.1.8 (19%),Phosphoric diester hydrolases (44%);DNA-directed DNA polymerase (19%);Peptidylprolyl isomerase (19%),GO:0016021 (42%);GO:0005886 (22%);GO:0005615 (21%),integral component of membrane (42%);plasma membrane (22%);extracellular space (21%),GO:0005164 (23%);GO:0005125 (21%);GO:0005524 (11%),tumor necrosis factor receptor binding (23%);cytokine activity (21%);ATP binding (11%),GO:0006955 (19%);GO:0097527 (9%);GO:0010573 (7%),immune response (19%);necroptotic signaling pathway (9%);vascular endothelial growth factor production (7%),IPR008983 (20%);IPR002959 (19%);IPR006052 (19%),Tumour necrosis factor-like domain superfamily (20%);Tumour necrosis factor alpha (19%);Tumour necrosis factor domain (19%)
MHLMHLYVPR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HFPMHLYVPR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MCGDDAAATK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
ELYLSWVNLAR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
YNGCLPAK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LSSPAAPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MHLMHLTAQSK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
QPMHLTEER,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MHMLHLYVPR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
KPMHLYHSK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FHPMHLYVPR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VMASPK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.6.1.1 (100%),Aspartate transaminase (100%),GO:0005634 (29%);GO:0005874 (11%);GO:0016021 (9%),nucleus (29%);microtubule (11%);integral component of membrane (9%),GO:0046872 (34%);GO:0004386 (23%);GO:0016787 (17%),metal ion binding (34%);helicase activity (23%);hydrolase activity (17%),GO:0006351 (23%);GO:0000226 (11%);GO:0007399 (11%),transcription, DNA-templated (23%);microtubule cytoskeleton organization (11%);nervous system development (11%),IPR001965 (21%);IPR011011 (21%);IPR013083 (21%),Zinc finger, PHD-type (21%);Zinc finger, FYVE/PHD-type (21%);Zinc finger, RING/FYVE/PHD-type (21%)
TGPNSGWGK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MHLMHLTASK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
WYYHLYVPR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VPGVPDLK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
EMWLSVQNK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
WYYHLTATNK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MHLMHLYPVR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MPLVGK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,6.3.5.1 (77%);1.11.1.26 (6%);6.3.1.5 (6%),NAD(+) synthase (glutamine-hydrolyzing) (77%);NADH-dependent peroxiredoxin (6%);NAD(+) synthase (6%),GO:0005737 (67%);GO:0016021 (10%);GO:0005886 (2%),cytoplasm (67%);integral component of membrane (10%);plasma membrane (2%),GO:0005524 (65%);GO:0003952 (62%);GO:0004359 (61%),ATP binding (65%);NAD+ synthase (glutamine-hydrolyzing) activity (62%);glutaminase activity (61%),GO:0009435 (62%);GO:0006979 (5%);GO:0030632 (3%),NAD biosynthetic process (62%);response to oxidative stress (5%);D-alanine biosynthetic process (3%),IPR003694 (59%);IPR014729 (59%);IPR022310 (59%),NAD(+) synthetase (59%);Rossmann-like alpha/beta/alpha sandwich fold (59%);NAD/GMP synthase (59%)
YGNALSWVLWR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
GSGGGSSGGSLGGR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0045095 (100%);GO:0005886 (53%);GO:0001533 (44%),keratin filament (100%);plasma membrane (53%);cornified envelope (44%),GO:0046982 (47%);GO:0030246 (44%);GO:0030280 (44%),protein heterodimerization activity (47%);carbohydrate binding (44%);structural constituent of skin epidermis (44%),GO:0050728 (47%);GO:0051290 (47%);GO:0061436 (47%),negative regulation of inflammatory response (47%);protein heterotetramerization (47%);establishment of skin barrier (47%),IPR032449 (100%);IPR003054 (97%);IPR039008 (97%),Keratin type II cytoskeletal 1, tail (100%);Keratin, type II (97%);Intermediate filament, rod domain (97%)
LVNELTEFAK,Mammalia,Eukaryota,Metazoa,,,Chordata,Craniata,Sarcopterygii,Mammalia,,,,,,,,,,,,,,,,,,,,,,,GO:0005615 (88%);GO:0032991 (17%);GO:0005783 (13%),extracellular space (88%);protein-containing complex (17%);endoplasmic reticulum (13%),GO:0046872 (71%);GO:0003677 (17%);GO:0005504 (17%),metal ion binding (71%);DNA binding (17%);fatty acid binding (17%),GO:0009267 (17%);GO:0043066 (17%);GO:0051659 (17%),cellular response to starvation (17%);negative regulation of apoptotic process (17%);maintenance of mitochondrion location (17%),IPR000264 (100%);IPR014760 (100%);IPR020858 (100%),ALB/AFP/VDB (100%);Serum albumin, N-terminal (100%);Serum albumin-like (100%)
SLVNLGGSK,Mammalia,Eukaryota,Metazoa,,,Chordata,Craniata,Sarcopterygii,Mammalia,,,,,,,,,,,,,,,,,,,,,,,GO:0045095 (100%);GO:0005886 (61%);GO:0001533 (33%),keratin filament (100%);plasma membrane (61%);cornified envelope (33%),GO:0046982 (35%);GO:0030246 (33%);GO:0030280 (33%),protein heterodimerization activity (35%);carbohydrate binding (33%);structural constituent of skin epidermis (33%),GO:0051290 (35%);GO:0001867 (33%);GO:0018149 (33%),protein heterotetramerization (35%);complement activation, lectin pathway (33%);peptide cross-linking (33%),IPR003054 (100%);IPR032444 (100%);IPR039008 (100%),Keratin, type II (100%);Keratin type II head (100%);Intermediate filament, rod domain (100%)
LAHTTTK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.8.7.1 (100%),Assimilatory sulfite reductase (ferredoxin) (100%),GO:0016021 (11%);GO:0005681 (6%);GO:0005886 (6%),integral component of membrane (11%);spliceosomal complex (6%);plasma membrane (6%),GO:0020037 (89%);GO:0046872 (89%);GO:0050311 (89%),heme binding (89%);metal ion binding (89%);sulfite reductase (ferredoxin) activity (89%),GO:0000398 (6%);GO:0006779 (6%);GO:0042168 (6%),mRNA splicing, via spliceosome (6%);porphyrin-containing compound biosynthetic process (6%);heme metabolic process (6%),IPR005117 (89%);IPR006066 (89%);IPR006067 (89%),Nitrite/Sulfite reductase ferredoxin-like domain (89%);Nitrite/sulphite reductase iron-sulphur/sirohaem-binding site (89%);Nitrite/sulphite reductase 4Fe-4S domain (89%)
VATVSLPR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.4.21.4 (100%),Trypsin (100%),GO:0005615 (29%),extracellular space (29%),GO:0004252 (100%);GO:0046872 (14%),serine-type endopeptidase activity (100%);metal ion binding (14%),GO:0006508 (29%);GO:0007586 (14%),proteolysis (29%);digestion (14%),IPR001254 (100%);IPR001314 (100%);IPR009003 (100%),Serine proteases, trypsin domain (100%);Peptidase S1A, chymotrypsin family (100%);Peptidase S1, PA clan (100%)
SLSLSVAR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.5.5.1 (50%);3.5.99.2 (50%),Electron-transferring-flavoprotein dehydrogenase (50%);Aminopyrimidine aminohydrolase (50%),GO:0045095 (92%);GO:0005886 (47%);GO:0001533 (37%),keratin filament (92%);plasma membrane (47%);cornified envelope (37%),GO:0030280 (37%);GO:0046982 (36%);GO:0030246 (35%),structural constituent of skin epidermis (37%);protein heterodimerization activity (36%);carbohydrate binding (35%),GO:0018149 (37%);GO:0051290 (36%);GO:0001867 (35%),peptide cross-linking (37%);protein heterotetramerization (36%);complement activation, lectin pathway (35%),IPR032444 (92%);IPR003054 (91%);IPR039008 (91%),Keratin type II head (92%);Keratin, type II (91%);Intermediate filament, rod domain (91%)
YLYELAR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.1.35 (57%);2.5.1.7 (14%);2.7.13.3 (14%),Pyridoxal kinase (57%);UDP-N-acetylglucosamine 1-carboxyvinyltransferase (14%);Histidine kinase (14%),GO:0005615 (86%);GO:0005737 (19%);GO:0032991 (9%),extracellular space (86%);cytoplasm (19%);protein-containing complex (9%),GO:0046872 (43%);GO:0005504 (14%);GO:0003677 (9%),metal ion binding (43%);fatty acid binding (14%);DNA binding (9%),GO:0001542 (13%);GO:0042448 (13%);GO:0060395 (13%),ovulation from ovarian follicle (13%);progesterone metabolic process (13%);SMAD protein signal transduction (13%),IPR000264 (90%);IPR014760 (90%);IPR020858 (90%),ALB/AFP/VDB (90%);Serum albumin, N-terminal (90%);Serum albumin-like (90%)
LGEHNLDVL,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VVTLVSPR,Bacteria,Bacteria,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0016020 (100%),membrane (100%),GO:0008137 (100%);GO:0051539 (100%),NADH dehydrogenase (ubiquinone) activity (100%);4 iron, 4 sulfur cluster binding (100%),GO:0042773 (100%),ATP synthesis coupled electron transport (100%),IPR000283 (100%);IPR001041 (100%);IPR006656 (100%),NADH:ubiquinone oxidoreductase, 75kDa subunit, conserved site (100%);2Fe-2S ferredoxin-type iron-sulfur binding domain (100%);Molybdopterin oxidoreductase (100%)
NNMTQK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,6.1.1.14 (64%);2.7.7.6 (14%);1.8.4.11 (7%),Glycine--tRNA ligase (64%);DNA-directed RNA polymerase (14%);Peptide-methionine (S)-S-oxide reductase (7%),GO:0005737 (41%);GO:0016021 (7%);GO:0000502 (4%),cytoplasm (41%);integral component of membrane (7%);proteasome complex (4%),GO:0003677 (41%);GO:0005524 (37%);GO:0004820 (33%),DNA binding (41%);ATP binding (37%);glycine-tRNA ligase activity (33%),GO:0006426 (33%);GO:0006351 (7%);GO:0009405 (7%),glycyl-tRNA aminoacylation (33%);transcription, DNA-templated (7%);obsolete pathogenesis (7%),IPR002315 (33%);IPR004154 (33%);IPR006195 (33%),Glycyl-tRNA synthetase (33%);Anticodon-binding (33%);Aminoacyl-tRNA synthetase, class II (33%)
MVLDLSGFK,Delftia,Bacteria,,,,Proteobacteria,,,Betaproteobacteria,,,Burkholderiales,,,,Comamonadaceae,,,,Delftia,,,,,,,,,,,,,,GO:0030246 (100%);GO:0004180 (33%),carbohydrate binding (100%);carboxypeptidase activity (33%),,,IPR011050 (100%);IPR013783 (100%);IPR013784 (100%),Pectin lyase fold/virulence factor (100%);Immunoglobulin-like fold (100%);Carbohydrate-binding-like fold (100%)
LLHLR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.4.1.182 (24%);2.7.2.4 (18%);3.6.-.- (8%),Lipid-A-disaccharide synthase (24%);Aspartate kinase (18%);Acting on acid anhydrides (8%),GO:0016021 (17%);GO:0005737 (6%);GO:0005886 (3%),integral component of membrane (17%);cytoplasm (6%);plasma membrane (3%),GO:0005524 (16%);GO:0043531 (8%);GO:0046872 (7%),ATP binding (16%);ADP binding (8%);metal ion binding (7%),GO:0009245 (6%);GO:0009089 (4%);GO:0009088 (4%),lipid A biosynthetic process (6%);lysine biosynthetic process via diaminopimelate (4%);threonine biosynthetic process (4%),IPR027417 (18%);IPR032675 (9%);IPR017853 (6%),P-loop containing nucleoside triphosphate hydrolase (18%);Leucine-rich repeat domain superfamily (9%);Glycoside hydrolase superfamily (6%)
LSGSGGR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.6.4.12 (44%);3.1.-.- (38%);2.4.2.- (25%),DNA helicase (44%);Acting on ester bonds (38%);Pentosyltransferases (25%),GO:0016021 (32%);GO:0005634 (13%);GO:0005694 (10%),integral component of membrane (32%);nucleus (13%);chromosome (10%),GO:0005524 (18%);GO:0003677 (15%);GO:0046872 (11%),ATP binding (18%);DNA binding (15%);metal ion binding (11%),GO:0006281 (11%);GO:0033567 (10%);GO:0006811 (8%),DNA repair (11%);DNA replication, Okazaki fragment processing (10%);ion transport (8%),IPR006153 (13%);IPR027417 (13%);IPR038770 (10%),Cation/H+ exchanger (13%);P-loop containing nucleoside triphosphate hydrolase (13%);Sodium/solute  symporter  superfamily (10%)
NPPVGFLGK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LPNTLLAAGGSYK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VAEVSLPR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
RPVSLPR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.1.2.11 (97%);2.3.1.20 (1%);2.3.3.14 (1%),3-methyl-2-oxobutanoate hydroxymethyltransferase (97%);Diacylglycerol O-acyltransferase (1%);Homocitrate synthase (1%),GO:0005737 (74%);GO:0016021 (2%);GO:0005886 (1%),cytoplasm (74%);integral component of membrane (2%);plasma membrane (1%),GO:0046872 (86%);GO:0003864 (74%);GO:0008168 (72%),metal ion binding (86%);3-methyl-2-oxobutanoate hydroxymethyltransferase activity (74%);methyltransferase activity (72%),GO:0015940 (74%);GO:0032259 (72%);GO:0045892 (4%),pantothenate biosynthetic process (74%);methylation (72%);negative regulation of transcription, DNA-templated (4%),IPR003700 (73%);IPR015813 (73%);IPR040442 (73%),Ketopantoate hydroxymethyltransferase (73%);Pyruvate/Phosphoenolpyruvate kinase-like domain superfamily (73%);Pyruvate kinase-like domain superfamily (73%)
LNDKPVK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.4.1.16 (50%);3.4.21.102 (25%);3.6.3.41 (25%),Chitin synthase (50%);C-terminal processing peptidase (25%);Transferred entry: 7.6.2.5 (25%),GO:0016021 (33%);GO:0005886 (13%),integral component of membrane (33%);plasma membrane (13%),GO:0004252 (33%);GO:0005524 (27%);GO:0016887 (20%),serine-type endopeptidase activity (33%);ATP binding (27%);ATPase (20%),GO:0006031 (13%);GO:0055085 (7%),chitin biosynthetic process (13%);transmembrane transport (7%),IPR001478 (50%);IPR036034 (50%);IPR001940 (25%),PDZ domain (50%);PDZ superfamily (50%);Peptidase S1C (25%)
NLLALMK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.7.6 (50%);1.17.4.2 (10%);2.3.3.9 (10%),DNA-directed RNA polymerase (50%);Ribonucleoside-triphosphate reductase (thioredoxin) (10%);Malate synthase (10%),GO:0016021 (29%);GO:0005634 (21%);GO:0005737 (6%),integral component of membrane (29%);nucleus (21%);cytoplasm (6%),GO:0003677 (15%);GO:0003899 (15%);GO:0008270 (15%),DNA binding (15%);DNA-directed 5'-3' RNA polymerase activity (15%);zinc ion binding (15%),GO:0006351 (15%);GO:0000742 (6%);GO:0006189 (6%),transcription, DNA-templated (15%);karyogamy involved in conjugation with cellular fusion (6%);'de novo' IMP biosynthetic process (6%),IPR001646 (16%);IPR000722 (13%);IPR006592 (13%),Pentapeptide repeat (16%);RNA polymerase, alpha subunit (13%);RNA polymerase, N-terminal (13%)
HLLNPYAK,Proteobacteria,Bacteria,,,,Proteobacteria,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0016021 (100%),integral component of membrane (100%),GO:0008324 (100%),cation transmembrane transporter activity (100%),GO:0006813 (100%),potassium ion transport (100%),IPR003148 (100%);IPR006037 (100%);IPR013099 (100%),Regulator of K+ conductance, N-terminal (100%);Regulator of K+ conductance, C-terminal (100%);Potassium channel domain (100%)
GLGLTAHLTTGQAG,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LLLAPFK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.4.1.227 (83%);1.14.11.2 (17%),Undecaprenyldiphospho-muramoylpentapeptide beta-Nacetylglucosaminyltransferase (83%);Procollagen-proline 4-dioxygenase (17%),GO:0016021 (21%);GO:0005634 (12%);GO:0005886 (12%),integral component of membrane (21%);nucleus (12%);plasma membrane (12%),GO:0050511 (15%);GO:0051991 (15%);GO:0003677 (12%),undecaprenyldiphospho-muramoylpentapeptide beta-N-acetylglucosaminyltransferase activity (15%);UDP-N-acetyl-D-glucosamine:N-acetylmuramoyl-L-alanyl-D-glutamyl-meso-2,6-diaminopimelyl-D-alanyl-D-alanine-diphosphoundecaprenol 4-beta-N-acetylglucosaminlytransferase activity (15%);DNA binding (12%),GO:0007049 (18%);GO:0005975 (15%);GO:0030259 (15%),cell cycle (18%);carbohydrate metabolic process (15%);lipid glycosylation (15%),IPR004276 (14%);IPR006009 (11%);IPR007235 (11%),Glycosyltransferase family 28, N-terminal domain (14%);N-acetylglucosaminyltransferase, MurG (11%);Glycosyl transferase, family 28, C-terminal (11%)
DLNYAEDAVLLSSFEK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
AATEPLR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,4.1.1.31 (58%);2.8.3.- (27%);3.1.2.1 (4%),Phosphoenolpyruvate carboxylase (58%);CoA-transferases (27%);Acetyl-CoA hydrolase (4%),GO:0005634 (3%);GO:0016021 (2%);GO:0005886 (1%),nucleus (3%);integral component of membrane (2%);plasma membrane (1%),GO:0003986 (29%);GO:0008775 (29%);GO:0000287 (28%),acetyl-CoA hydrolase activity (29%);acetate CoA-transferase activity (29%);magnesium ion binding (28%),GO:0006083 (29%);GO:0006084 (29%);GO:0019679 (29%),acetate metabolic process (29%);acetyl-CoA metabolic process (29%);propionate metabolic process, methylcitrate cycle (29%),IPR003702 (25%);IPR017821 (25%);IPR026888 (25%),Acetyl-CoA hydrolase/transferase (25%);Succinate CoA transferase (25%);Acetyl-CoA hydrolase/transferase C-terminal domain (25%)
ATAGALPR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0019033 (100%);GO:0030430 (100%);GO:0042025 (100%),viral tegument (100%);host cell cytoplasm (100%);host cell nucleus (100%),GO:0019784 (100%),NEDD8-specific protease activity (100%),GO:0039648 (100%);GO:0039693 (100%),modulation by virus of host protein ubiquitination (100%);viral DNA genome replication (100%),IPR005210 (100%);IPR006928 (100%);IPR038765 (100%),Herpesvirus large tegument protein deneddylase (100%);Herpesvirus large tegument protein, USP domain (100%);Papain-like cysteine peptidase superfamily (100%)
GGERPAPSR,Laccaria bicolor S238N-H82,Eukaryota,Fungi,Dikarya,,Basidiomycota,Agaricomycotina,,Agaricomycetes,Agaricomycetidae,,Agaricales,,,,Tricholomataceae,,,,Laccaria,,,,Laccaria bicolor,,Laccaria bicolor S238N-H82,,,,,,GO:0016021 (100%),integral component of membrane (100%),,,,,,
LPPDVDR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.4.21.89 (100%),Signal peptidase I (100%),GO:0005737 (26%);GO:0016021 (5%);GO:0005886 (2%),cytoplasm (26%);integral component of membrane (5%);plasma membrane (2%),GO:0003779 (89%);GO:0046872 (68%);GO:0004252 (2%),actin binding (89%);metal ion binding (68%);serine-type endopeptidase activity (2%),GO:0007010 (89%);GO:0032259 (2%),cytoskeleton organization (89%);methylation (2%),IPR036886 (79%);IPR003128 (77%);IPR001781 (61%),Villin headpiece domain superfamily (79%);Villin headpiece (77%);Zinc finger, LIM-type (61%)
RPLLFLR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.4.1.24 (100%),3-dehydroquinate synthase II (100%),GO:0016021 (68%);GO:0005886 (4%);GO:0016020 (4%),integral component of membrane (68%);plasma membrane (4%);membrane (4%),GO:0008081 (16%);GO:0005524 (8%);GO:0010181 (8%),phosphoric diester hydrolase activity (16%);ATP binding (8%);FMN binding (8%),GO:0006629 (16%);GO:0000398 (4%);GO:0006298 (4%),lipid metabolic process (16%);mRNA splicing, via spliceosome (4%);mismatch repair (4%),IPR001810 (13%);IPR006527 (13%);IPR017451 (13%),F-box domain (13%);F-box associated domain, type 1 (13%);F-box associated interaction domain (13%)
MAALALLLQK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VVENTGAR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SSPATLNSR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TDVVLLDNVLFPVK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LTSNATRPL,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
GALLVLTFDGK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LAGTTGPLSGK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
GVCLK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.11.25 (52%);3.1.3.16 (10%);2.7.7.6 (7%),Mitogen-activated protein kinase kinase kinase (52%);Protein-serine/threonine phosphatase (10%);DNA-directed RNA polymerase (7%),GO:0015935 (43%);GO:0016021 (6%);GO:0005739 (5%),small ribosomal subunit (43%);integral component of membrane (6%);mitochondrion (5%),GO:0003735 (45%);GO:0019843 (23%);GO:0000049 (23%),structural constituent of ribosome (45%);rRNA binding (23%);tRNA binding (23%),GO:0006412 (45%);GO:0046777 (2%);GO:0006351 (2%),translation (45%);protein autophosphorylation (2%);transcription, DNA-templated (2%),IPR012340 (41%);IPR006032 (40%);IPR005679 (39%),Nucleic acid-binding, OB-fold (41%);Ribosomal protein S12/S23 (40%);Ribosomal protein S12, bacterial-type (39%)
QVANGVPVR,Bacteria,Bacteria,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.1.3.2 (100%),Aspartate carbamoyltransferase (100%),,,GO:0004070 (100%);GO:0016597 (100%),aspartate carbamoyltransferase activity (100%);amino acid binding (100%),GO:0006207 (100%);GO:0006520 (100%);GO:0044205 (100%),'de novo' pyrimidine nucleobase biosynthetic process (100%);cellular amino acid metabolic process (100%);'de novo' UMP biosynthetic process (100%),IPR002082 (100%);IPR006130 (100%);IPR006131 (100%),Aspartate carbamoyltransferase (100%);Aspartate/ornithine carbamoyltransferase (100%);Aspartate/ornithine carbamoyltransferase, Asp/Orn-binding domain (100%)
SVPVK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.3.1.61 (14%);1.2.4.2 (13%);4.2.1.3 (7%),Dihydrolipoyllysine-residue succinyltransferase (14%);Oxoglutarate dehydrogenase (succinyl-transferring) (13%);Aconitate hydratase (7%),GO:0016021 (17%);GO:0005737 (10%);GO:0005886 (5%),integral component of membrane (17%);cytoplasm (10%);plasma membrane (5%),GO:0003723 (12%);GO:0005524 (8%);GO:0046872 (8%),RNA binding (12%);ATP binding (8%);metal ion binding (8%),GO:0045893 (5%);GO:0006099 (3%);GO:0042121 (3%),positive regulation of transcription, DNA-templated (5%);tricarboxylic acid cycle (3%);alginic acid biosynthetic process (3%),IPR012677 (8%);IPR002942 (8%);IPR036986 (8%),Nucleotide-binding alpha-beta plait domain superfamily (8%);RNA-binding S4 domain (8%);RNA-binding S4 domain superfamily (8%)
TQPLALTELK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,